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This work describes a freely available web-based facility which can be used to analyse raw or processed mass spec-
trometric data from metabolomics experiments and display the metabolites identiﬁed – and changes in their
experimental abundance – in the context of the metabolic pathways in which they occur. The facility, Pathos
(http://motif.gla.ac.uk/Pathos/), employs Java servlets and is underpinned by a relational database populated from
the Kyoto Encyclopaedia of Genes and Genomes (KEGG). Input ﬁles can contain either raw m/z values from
experiments conducted in different modes, or KEGG or MetaCyc IDs assigned by the user on the basis of the
m/z values and other criteria. The textual output lists the KEGG pathways on an XHTML page according to the
number of metabolites or potential metabolites that they contain. Filtering by organism is also available. For
metabolic pathways of interest, the user is able to retrieve a pathway map with identiﬁed metabolites highlighted.
A particular feature of Pathos is its ability to process relative quantiﬁcation data for metabolites identiﬁed under
different experimental conditions, and to present this in an easily comprehensible manner. Results are colour-
coded according to the degree of experimental change, and bar charts of the results can be generated interactively
from either the text listings or the pathway maps. The visual presentation of the output from Pathos is designed to
allow the rapid identiﬁcation of metabolic areas of potential interest, after which particular results may be examined
in detail. Copyright © 2011 John Wiley & Sons, Ltd.
(wileyonlinelibrary.com) DOI: 10.1002/rcm.5245The application of high-resolution mass spectrometry to the
analysis of the abundance of small molecules[1] has allowed
large numbers of cellular metabolites to be identiﬁed simulta-
neously and changes in their concentrations to be studied
under different experimental conditions. Raw data from mass
spectrometry typically contain both noise and a large number
of genuine metabolite peaks, and sophisticated methods have
been developed for reﬁning these data and determining the
possible molecular formulae corresponding to each detected
molecular mass (reviewed in Castillo et al.[2]). The ﬁrst stages
of such reﬁnement typically involve peak detection, ﬁltering,
grouping, and sample alignment.[3,4] Exact molecular mass
alone does not generally allow unequivocal identiﬁcation of
metabolites because of the existence of isomers, so this stage
may be followed by attempts at identiﬁcation and annotation
on the basis of a variety of criteria,[5–7] using MS/MS fragmen-
tation or chromatographic information,[8] and considering the* Correspondence to: D. P. Leader, Joseph Black Building,
University of Glasgow, Glasgow G12 8QQ, UK.
E-mail: david.leader@glasgow.ac.uk
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Applications exist to integrate these different stages into a
single tool or pipeline.[7,10]
A ﬁnal stage in this pipeline is integrating identiﬁed com-
pounds into a visual metabolic context, and there are two
broad approaches to this. One is to generate network dia-
grams.[11–13] Although this can be very powerful, biologists
often wish to view metabolites in the context of a representa-
tion of metabolic pathways with which they are more familiar.
KEGG has developed a Mapper tool[14] that enables interactive
imposition and colour highlighting of metabolites in their path-
way maps, and this interactive approach has been extended
further in iPath.[15] However, these facilities are not designed
for routine analysis of mass spectrometry data. Bespoke facil-
ities[16,17] for visualizing metabolites from mass spectrometry
have been provided for the different representations offered
by the two main databases of metabolic pathways,MetaCyc[18]
and KEGG.[19] The MassTRIX facility,[17] which employs the
KEGG pathways environment to represent metabolomics data,
has been a useful and simple tool with which to contextualize
metabolomics data sets. However, in relation to our own work,
it lacked an important feature, namely the ability to accept
and display comparative data from different experimentalCopyright © 2011 John Wiley & Sons, Ltd.
Pathos: Metabolomics web facilityconditions. Pathos, the metabolomics web facility described
here, fulﬁls this requirement and, in addition, is able to accept
identiﬁed metabolites as an alternative to m/z values with
rapid feedback of results, thus expanding the range of data
types that can be analyzed.342EXPERIMENTAL
The MySQL relational database underlying Pathos contains
tables of data for metabolites, for pathway maps and for
organisms, and is described in the Supporting Information.
The database was populated from ﬁles downloaded from
the KEGG FTP site[20] after processing with parsers written
in Java for the purpose.
The core of the web facility is a Java servlet, the source code
for which may be downloaded from the internet[21] and used
under GPL license conditions. The servlet loads the data for
the user-speciﬁed organism (or all organisms) from the data-
base and holds it in memory in the form of objects represent-
ing pathway maps. Metabolites or potential metabolites
derived from the user’s uploaded input ﬁle are added to
these pathway objects. If the input ﬁle lists KEGG or MetaCyc
IDs this is done directly. If the input ﬁle contains m/z values
from analysis performed in positive or negative ion mode,
possible neutral exact masses are calculated (for the most
abundant isotope of each atom) by considering each of a
number of possible adducts: 32 in the case of positive mode,
and 15 in the case of negative mode (listed at[22]). Potential
metabolites are then assigned from these neutral masses,
according to the degree of mass accuracy selected by the user,
and this latter procedure is what occurs if the user uploads
m/z values in ’neutral mode’ (i.e. m/z values from positive or
negative mode that have been adjusted by pre-processing soft-
ware, usually assuming that the charged species resulted from
the gain or loss, respectively, of a proton). If a metabolite in an
experimental data set is identiﬁed on the basis of more than
one m/z value (e.g. from different adducts) only the data con-
taining the highest value are taken and the others discarded.
The metabolite information in the pathway objects is for-
mulated as an XML-processable XHTML page, which is
returned to the client. This page has several interactive user
options that employ additional server software. Customized
images of pathway maps may be generated via a Perl CGI
application that makes use of KEGG web services, column
charts of the results of experiments may be generated from
a small bespoke Java servlet, MSCompare, and details of
metabolites may be generated from a small bespoke Perl
CGI application, formula.cgi.
As the processing is all performed on the server, the demands
that Pathos makes on the user’s hardware and software are
extremely modest. Operating systems as old as Windows XP
and Mac OS X 10.4 have been found to be quite adequate with
standard web browsers such as Firefox, Safari, Chrome or Opera
(with JavaScript enabled). Unfortunately, Microsoft Internet
Explorer presents technical problems that exclude its use. We
currently run the public version of the Pathos web application
on a 2.2 GHz dual-processor machine running Linux, the Sun
Java System Web Server 7.0, and MySQL server version 5.
However, in developmental and on local intranets we have
employed desktop and laptop machines with lowerCopyright © 2011 JRapid Commun. Mass Spectrom. 2011, 25, 3422–3426conﬁgurations: single 1.4 GHz processors, Apache Tomcat 4.1,
andMySQL server version 4.RESULTS
We illustrate the use of Pathos with ’exptmz.txt’, one of the
experimental ﬁles that can be downloaded from the home
page.[23] The focus of this description is on the output
obtained – instructions, including details of ﬁle formats, are
available on-line or as a downloadable PDF ﬁle. The ﬁle
’exptmz.txt’ contains m/z values from a mass spectrometry
analysis (performed in positive ion mode) of wild-type and
glucose transporter-defective Leishmania mexicana.[24] On
uploading the ﬁle from the home page, the Java servlet
returns a page of analysis options and conﬁrmation of the
number of peaks read (Fig. 1). The user may choose from a list
of organisms (or accept the default of ’All Organisms’), from
a range of adducts appropriate to the analytical method (a
’base’ set is selected by default), and may alter the mass toler-
ance (in ppm) if desired. To allow colour highlighting of
changes in the concentration of metabolites in experiments
with multiple conditions, ’base’ and ’experimental’ condi-
tions are speciﬁed in the input ﬁle. These speciﬁcations are
displayed on pull-down lists, but may be changed by the user
at any time during a session.
After running the analysis a web page is returned with
pathway listings initially shown as summaries sorted by the
number of identiﬁed metabolites in a pathway, allowing a
quick overall survey of the results. Individual listings of inter-
est may be expanded to reveal the details of the (putative)
metabolites, as is shown for Arginine and Proline metabolism
in Fig. 2. The ’G’ (graph) symbol to the left of the name of
each metabolite is a hyperlink that can be clicked to generate
a column chart of the experimental changes for the metabolite
(ﬂoating pop-up in Fig. 2). The ’G’s are colour-coded to indi-
cate the degree of change (dark blue – most positive, dark red
– most negative) allowing the user to focus on those metabo-
lites that show the greatest changes with respect to induced
perturbation. (There is an option to expand all the listings at
once for the user who wishes to scan them for metabolites
that have undergone experimental changes.)
It is recognized that identiﬁcation of metabolites by exact
mass (even within a mass accuracy of 1 ppm) is insufﬁcient
when all possible molecular formulae are considered;[25] how-
ever, annotation of formulae by exact mass (i.e. from accurate
m/z data) is sufﬁcient for most formulae of knownmetabolites
in the KEGG database (only eight overlapping pairs were
found within a tolerance of 2 ppm in ca. 2300 metabolites –
see Supporting Information). Nevertheless, there are many
cases in which formulae correspond to multiple isomers in
the database, thus preventing accurate identiﬁcation of
metabolites from m/z data. The user is alerted to this latter
problem by the pathway listings, as follows. Metabolites,
the formulae of which are not represented by isomers in the
database (i.e. which are more likely to have been correctly
identiﬁed), have an asterisk appended, those with isomers
that are not present in the current pathway have a dagger
appended, and those with isomers that are present in the cur-
rent pathway have the number of such isomers appended in
parentheses (visible in Fig. 2). Furthermore, if the cursor is
held over a formula, all instances of it are highlighted. Awileyonlinelibrary.com/journal/rcmohn Wiley & Sons, Ltd.
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Figure 1. Pathos: view of an XHTML page showing options following upload of
ﬁlem/z values from a mass spectrometry analysis performed in positive ion mode
for an experiment comparing wild-type L. mexicana with a glucose transporter-
defective mutant. With the exception of the organism selection, the settings shown
are the defaults.
D. P. Leader et al.
3424facility is also provided whereby clicking on the name of a
metabolite generates a small pop-up window containing a
complete list of isomers of the same mass in the database. (This
window also presents the molecular structure of the metabolite
– not illustrated, but see Supporting Information.)
In the case of positive or negative mode m/z data, the
adduct for the most intense peak is indicated in parentheses.
At the foot of the page there is a listing of the molecular for-
mulae corresponding to each of the identiﬁed peaks, with
the adduct indicated, whether or not the peak was used in
the pathway sections. Listings of unidentiﬁed peaks and of
pathways lacking metabolites are also provided.Figure 2. Pathos: view of textual output fo
experimental results for a particular metabo
wileyonlinelibrary.com/journal/rcm Copyright © 2011 John WilEach pathway is furnished with an option that allows the
user to generate an annotated map through a call to the KEGG
web service. (Generation of the pathway map by the KEGG
web services takes 15 s or longer, so that a temporary ’busy’
icon is provided in the place where the map would appear
to reassure the user that the call has not failed.) A portion of
such a map is shown in Fig. 3, where it can be seen that those
circles representing identiﬁed metabolites are colour-coded in
the same manner as the ’G’s, above. They are also hyperlinks,
and clicking them invokes the corresponding column chart.
The map and column-chart graphics are PNG images which
can be saved to disc.llowing analysis, and column chart of
lite. For explanation, see text.
ey & Sons, Ltd. Rapid Commun. Mass Spectrom. 2011, 25, 3422–3426
Figure 3. Pathos: metabolic pathway map. The map window has been decreased
in size for convenience, and the visible portion chosen to illustrate a clustering of
identiﬁedmetabolites, some of which had increased in concentration in the mutant
(blue circles). The light-green background for the EC numbers of particular
enzymes indicates that they are predicted to be present in the genome of Leishmania
major (a parasite closely related to L. mexicana).
Pathos: Metabolomics web facilityIf the user provides a ﬁle containing either KEGG orMetaCyc
IDs, rather than m/z values, operation and results are similar,
but an appropriately simpler interface and results listing are
provided. If the data are simply in a single list of m/z values
or IDs, there is, of course, no option for a bar chart, and all of
the identiﬁed metabolites on the maps are coloured yellow.342DISCUSSION
The functionality of Pathos overlaps to a certain extent with
that of MassTRIX,[17] but some key novel features are built
into Pathos. The focus in MassTRIX is the identiﬁcation of
potential metabolites from m/z data, and it is appropriate that
the colour-coding of the pathway maps indicates the relation-
ship of the occurrence of the metabolite in the organism and
in the experimental data. The focus of Pathos, in contrast, is
presentation of relative quantiﬁcation of experimental results,
and was designed in the context of an increasing tendency to
pre-process the mass spectrometric data to produce input ﬁles
with metabolites, the identities of which are already known.
Hence, the colour-coding of the metabolic intermediates –
the simplest but most effective visualization technique avail-
able for pathway maps – is employed to inform the user of
metabolites which have undergone quantitative changes, the
details of which are instantly accessible by interacting with
the map. A more minor difference – although of practical rele-
vance – is that MassTRIX provides an extremely comprehen-
sive analysis of an m/z dataset, but this typically takes many
hours to produce. Pathos is designed to be more immediate
by providing minimal essential output initially, while allow-
ing users to select subsequently which maps or column charts
they wish to generate.
There are some other web applications, such as Metabo-
Analyst[26] and metaP-server,[27] that focus on experimental
comparisons analyzed by mass spectrometry. These have aCopyright © 2011 JRapid Commun. Mass Spectrom. 2011, 25, 3422–3426strong emphasis on statistical analysis of results, in contrast
to Pathos, which is essentially a presentation tool and per-
forms no statistical analysis, merely displaying in the column
charts any pre-determined standard deviations included in
the user’s input ﬁle.CONCLUSIONS
The web application Pathos satisﬁes a need at the visualiza-
tion point of the pipeline for analyzing metabolomics data.
We have found that biological scientists appreciate its sim-
ple interface, its speed of response and the familiar format
in which their results are imposed on metabolic pathway
maps. There is scope for further improvement of the maps –
the delay in their generation through the KEGG web ser-
vice being a notable inconvenience, and the maps could
be made richer in certain respects. We hope to address
these points in the future, for example through integrating
the generation of the annotated pathway maps into the
Pathos application itself.SUPPORTING INFORMATION
Supporting information may be found in the online version of
this article.Acknowledgements
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